Research
The Department of Investigational Cancer Therapeutics has developed a world-class clinical trials program. Our objective is to perform molecular profiling and match patients with novel, targeted drugs in the early clinical trials setting.
Resources
Observer Program
We offer one short-term observer position each month.
Appointments & Referrals
For a referral to clinical trials with a new targeted drug, call (713) 792-1160, or visit our Contact Information page.